<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>0001.txt
<TEXT>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report:
January 24, 2001
Date of earliest event reported:
January 24, 2001
PFIZER INC.
(Exact name of registrant as specified in its charter)
Delaware 1-3619 13-5315170
(State or other (Commission File (I.R.S. Employer
jurisdiction of Number) Identification No.)
incorporation)
235 East 42nd Street
New York, New York 10017
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code:
(212) 573-2323
(Former name or former address, if changed since last report.)
Item 5. Other Events.
Attached and incorporated herein by reference as Exhibit 99 is a copy of a
press release of Pfizer Inc. dated January 24, 2001, reporting Pfizer's
financial results for the fourth quarter of 2000 and for the year 2000.
Item 7(c). Exhibits.
99 Press release of Pfizer Inc. dated January 24, 2001, reporting Pfizer's
financial results for the fourth quarter of 2000 and for the year 2000.
Signature
Under the requirements of the Securities Exchange Act of 1934, the registrant
has caused this report to be signed on its behalf by the authorized
undersigned.
PFIZER INC.
----------------------------
Date January 24, 2001
/s/ Margaret M. Foran
Name: Margaret M. Foran
Title: Vice President-Corporate Governance
</TEXT>
</DOCUMENT>